The Research Scholars Program in Public Health from Gilead Sciences supports innovative research on HIV and viral hepatitis by early-career investigators in low- and middle-income countries.
Funder: Gilead Sciences Research Scholars Program
Due Dates: August 28, 2026: Round 1 — One-Page Specific Aims deadline | December 2, 2026: Round 2 — Detailed Proposal deadline (invited only)
Funding Amounts: $100,000 per award (2 years, paid in annual installments); minimum 4 awards available
Summary: Supports innovative public health research by early-career investigators in low- and middle-income countries focusing on HIV and/or viral hepatitis.
Key Information: Research may not investigate specific Gilead products or involve interventional clinical trials.
The Gilead Sciences Research Scholars Program in Public Health provides competitive funding for innovative research projects led by emerging investigators. The program aims to advance scientific understanding and address unmet medical needs in global public health, with a focus on HIV and viral hepatitis (B, C, D). Since 2008, the program has invested over $36 million USD to support junior researchers and promote health equity worldwide. Each award funds up to $100,000 over two years, enabling recipients to conduct transformative research and contribute to sustainable development goals.